首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1461433

黏稠補充劑市場，依劑量，依關節炎類型，依最終用戶，依地理位置

Viscosupplementation Market, By Dosage, By Arthritis Type, By End User, By Geography

出版日期: 2024年03月18日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

黏稠補充劑市場預計 2024 年價值為 38.4 億美元，預計到 2031 年將達到 64.9 億美元，2024 年至 2031 年年複合成長率(CAGR) 為 7.8%。

報告範圍		報告詳情
基準年：	2023年	2023/2024 年市場規模：	38.4 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測期間 2023/2024 至 2030/2031 年複合成長率：	7.80%	2030/2031 價值預測：	64.9 億美元

黏稠補充劑市場佔有率 (%)，依地區，2024 年

黏彈性補充是一種用於治療骨關節炎膝蓋疼痛的骨科治療方法。它涉及將透明質酸（也稱為透明質酸）注射到膝關節中。透明質酸在關節中充當潤滑劑和減震器。它可以補充關節中因骨關節炎而減少的水平。透過補充受骨關節炎影響的膝蓋滑液的黏性，有助於減輕疼痛並提高活動能力。黏彈性補充療法是一種非手術治療選擇，可長時間緩解膝骨關節炎症狀。

市場動態：

全球黏稠補充劑市場是由老年人口不斷增加推動的，老年人口更容易患骨關節炎和相關的關節疼痛。據估計，目前全球有超過 3.3 億人患有骨關節炎。預計未來幾年這一數字將大幅增加。此外，人們對先進非侵入性治療替代方案的認知不斷增強，以及黏稠補充手術的優惠報銷政策正在推動市場發展。然而，市場成長可能會受到對膳食補充劑等替代治療方法的偏好以及透明質酸注射緩解疼痛的功效和持續時間的限制而受到限制。整合 3D 列印和機器人技術來開發針對患者的透明質酸配方，為該市場提供了利潤豐厚的機會。

研究的主要特點：

該報告對全球黏稠補充劑市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。
它闡明了不同區隔市場的潛在收入機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數介紹了全球黏稠補充劑市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球黏稠補充劑市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和金融分析師。
利害關係人可以透過用於分析全球黏稠補充劑市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
東協
澳洲
韓國
亞太地區其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
北非
中非
南非

第 9 章：競爭格局

Anika Therapeutics Inc
Seikagaku Corporation
Ferring Pharmaceuticals
Bioventus
Fidia Farmaceutici S.P.A.
Mylan N.V.
Sanofi S.A.
ORTHOGENRX
Teva Pharmaceutical Industries Ltd.
Johnson & Johnson
F. Hoffmann-La Roche AG
Zimmer Biomet
Aptissen
Wellchem Pharmaceuticals Pte Ltd.
Juniper Biologics
Ono Pharmaceutical Co., Ltd

第 10 章：分析師觀點

命運之輪
分析師觀點
連貫的機會圖

第 11 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI197

The viscosupplementation market is estimated to be valued at USD 3.84 Bn in 2024 and is expected to reach USD 6.49 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.8% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 3.84 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	7.80%	2030/2031 Value Projection:	US$ 6.49 Bn

Viscosupplementation Market Share (%), By Region, 2024

Viscosupplementation is an orthopedic treatment method used to manage osteoarthritis knee pain. It involves injecting hyaluronic acid, also known as hyaluronan, into the knee joint. Hyaluronic acid acts as a lubricant and shock absorber in the joints. It replenishes levels in the joint that diminish with osteoarthritis. This helps reduce pain and improve mobility by supplementing the viscous nature of the synovial fluid in knees affected by osteoarthritis. Viscosupplementation therapy is a non-surgical treatment option that provides relief from knee osteoarthritis symptoms for extended periods of time.

Market Dynamics:

The global viscosupplementation market is driven by the rising geriatric population which is more prone to develop osteoarthritis and the associated joint pains. As per estimates, over 330 million people currently suffer from osteoarthritis globally. This is projected to increase substantially in the coming years. Moreover, growing awareness about advanced non-invasive treatment alternatives and favorable reimbursement policies for viscosupplementation procedures are boosting the market. However, the market growth can be restrained by the preference for alternative treatment methods like dietary supplements and limitations in the efficacy and duration of pain relief provided by hyaluronic acid injections. The integration of 3D printing and robotic technologies to develop patient-specific hyaluronic acid formulations provides lucrative opportunities in this market.

Key Features of the Study:

This report provides in-depth analysis of the global viscosupplementation market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global viscosupplementation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Anika Therapeutics Inc., Seikagaku Corporation, Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., OrthogenRx, Teva Pharmaceutical Industries Ltd, Johnson & Johnson., F. Hoffmann-La Roche AG, Zimmer Biomet, Aptissen, Wellchem Pharmaceuticals Pte Ltd., Juniper Biologics, and Ono Pharmaceutical Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global viscosupplementation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global viscosupplementation market.

Market Segmentation

Dosage:
- Single Injection
- Three Injection
- Five Injection
Arthritis Type:
- Osteoarthritis
- Rheumatoid Arthritis
End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- Anika Therapeutics Inc.
- Seikagaku Corporation
- Ferring Pharmaceuticals
- Bioventus
- Fidia Farmaceutici S.P.A.
- Mylan N.V.
- Sanofi S.A.
- OrthogenRx
- Teva Pharmaceutical Industries Ltd
- Johnson & Johnson.
- Hoffmann-La Roche AG
- Zimmer Biomet
- Aptissen
- Wellchem Pharmaceuticals Pte Ltd.
- Juniper Biologics
- Ono Pharmaceutical Co., Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Dosage
- Market Snapshot, By Arthritis Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
PEST Analysis

4. Global Viscosupplementation Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the Market

5. Global Viscosupplementation Market, By Dosage, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Single Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Three Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Five Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

6. Global Viscosupplementation Market, By Arthritis Type, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Osteoarthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Rheumatoid Arthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

7. Global Viscosupplementation Market, By End User, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

8. Global Viscosupplementation Market, By Region, 2019 - 2031, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (US$ Billion)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Anika Therapeutics Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Seikagaku Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ferring Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bioventus
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Fidia Farmaceutici S.P.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ORTHOGENRX
Teva Pharmaceutical Industries Ltd.
Johnson & Johnson
F. Hoffmann-La Roche AG
Zimmer Biomet
Aptissen
Wellchem Pharmaceuticals Pte Ltd.
Juniper Biologics
Ono Pharmaceutical Co., Ltd